Page last updated: 2024-08-24

plerixafor and Malignant Mesothelioma

plerixafor has been researched along with Malignant Mesothelioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hou, S; Kadoch, O; Li, H; Li, J; Li, S; Li, T; Lin, Q; Xie, L; Xu, Z; Yang, YL	1

Other Studies

1 other study(ies) available for plerixafor and Malignant Mesothelioma

Article	Year
Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2019, Volume: 67, Issue:2 Topics: Animals; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Luminescent Measurements; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice, Inbred BALB C; Mice, Nude; Pemetrexed; Pleural Neoplasms; Protein Isoforms; Receptors, CXCR4; Signal Transduction	2019

Article

Year

Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2019, Volume: 67, Issue:2

Topics: Animals; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Luminescent Measurements; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice, Inbred BALB C; Mice, Nude; Pemetrexed; Pleural Neoplasms; Protein Isoforms; Receptors, CXCR4; Signal Transduction

2019